HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67,415 | -5.6% | 1,869 | 0.0% | 0.01% | -18.2% |
| Q1 2023 | $71,377 | -26.3% | 1,869 | +9.8% | 0.01% | -26.7% |
| Q4 2022 | $96,844 | +44.5% | 1,702 | 0.0% | 0.02% | +36.4% |
| Q3 2022 | $67,000 | -10.7% | 1,702 | 0.0% | 0.01% | -8.3% |
| Q2 2022 | $75,000 | +10.3% | 1,702 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $68,000 | -13.9% | 1,702 | -12.9% | 0.01% | -10.0% |
| Q4 2021 | $79,000 | 0.0% | 1,954 | 0.0% | 0.01% | -9.1% |
| Q3 2021 | $79,000 | -11.2% | 1,954 | 0.0% | 0.01% | -8.3% |
| Q2 2021 | $89,000 | +21.9% | 1,954 | +11.3% | 0.01% | +9.1% |
| Q1 2021 | $73,000 | -2.7% | 1,756 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $75,000 | +158.6% | 1,756 | +58.8% | 0.01% | +100.0% |
| Q3 2020 | $29,000 | – | 1,106 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |